Urinary Catheter Medicare Fraud: Claims for Catheters Nobody Ordered

Urinary catheter Medicare fraud allegations include phantom supplies billed under stolen Medicare identities and kickbacks used to steer catheter prescriptions. Inside a supplier or urology practice, the evidence is more ordinary than the headline: an order nobody recognizes, a shipment that never happened, or a prescription form chosen because the practice received something in return. The claim says the patient needed supplies. The people handling orders, referrals and fulfillment can explain how that claim came to exist.

The billing surge concentrated in particular products. In national catheter claims data from the Centers for Medicare & Medicaid Services, allowed charges for sterile catheter kits rose from $53,519,355 in 2022 to $3,907,243,789 in 2023. Curved-tip catheter billing also rose sharply, while straight-tip billing stayed much closer to its earlier level. Whether anyone was paid is a separate question.

What Is Typically Required Before a DME Supplier Can Process an Order?

A supplier needs the practitioner’s order and the clinical documentation supporting the patient’s eligibility for the catheter being billed. The supplier then connects that order to the product supplied, proof of delivery and the Medicare claim. For recurring supplies, the refill request belongs in that same chain.

Intermittent catheters are single-use supplies prescribed for people with urinary retention to drain the bladder several times a day. The clinician orders them, and the patient obtains them through a medical equipment supplier. The clinical office and the billing business therefore hold different parts of the story. A signature on the supplier’s form has to be read alongside the patient record that explains the need.

The supplier keeps the supporting documents and produces them when requested. That makes the date, authorship and transmission of an order useful evidence. A form arriving from a marketer, an order signed by a clinician and a claim submitted by the supplier are separate events, even when the finished file makes them look like one uninterrupted transaction.

Refills Need a Request Before Shipment

Medicare’s refill requirements require the supplier to document the beneficiary’s affirmative request before shipping. A statement added afterward does not replace that contact.

For a call-center employee or shipping worker, the comparison is concrete: the recorded request, its date, the shipment and the subsequent claim. An automatic shipment schedule can keep generating bills after the original order. The contact history shows whether the patient actually asked for the next supply.

A purchased lead also has its own history. Marketing, clinical authorization and fulfillment can sit in separate businesses. In that equipment sales pipeline, a telemedicine staffing company or physician network may supply the signing practitioner rather than the patient’s own treating clinician. We examine who obtained the beneficiary’s information, what the person requested and how that information reached the supplier. That is where a sales record can meet a medical order for the first time.

Why A4352 and A4353 Matter to Catheter Billing

A4351 identifies a straight-tip intermittent catheter, A4352 a coude or curved-tip catheter, and A4353 an intermittent catheter supplied with insertion supplies as a sterile kit. The distinction reaches both the product shipped and the patient’s medical record.

For a curved-tip catheter, Medicare’s urological-supplies policy requires documentation of medical necessity. Inability to catheterize with a straight-tip catheter is one example. The reason for the more specialized product belongs in the patient’s chart.

Sterile kits have additional coverage conditions. One qualifying route concerns documented recurrent urinary tract infections during a program of sterile intermittent catheterization. The kit also has to be supplied as a kit: separately packaged components do not qualify for the kit code. For closed-system catheter billing, the packaging, actual components and clinical support give the product description its meaning.

This is a useful place for purchasing and warehouse records to meet billing. Purchase invoices identify what the supplier bought. Fulfillment records identify what it sent. The claim identifies which catheter or kit Medicare was asked to pay for. We connect those records to the clinical reason for that particular product.

How Many Catheters Will Medicare Pay for Per Month?

Medicare’s usual maximum for the specified intermittent-catheter codes is 200 units per month, with a combined cap for sterile catheter kits. The urological-supplies coverage policy also requires support for the patient’s need and the kit’s additional coverage conditions.

A quantity ceiling limits the supplies billed for a person. A phantom-supply scheme can multiply claims across beneficiary identities while staying below that ceiling on each one. That is why the patient, order and delivery matter alongside the monthly count.

What Happens If DMEPOS Billing Is Improper?

Medicare can seek repayment and review additional claims. The inspector general’s February 2025 catheter audit shows exactly where the supporting records failed.

The audit examined supplies provided from July 2021 through June 2022. Payments for 15 of 105 sampled items failed Medicare requirements. The failures concerned medical records supporting curved-tip catheters or sterile kits, refill documentation, proof of delivery and standard written orders. The Office of Inspector General estimated that approximately $35.1 million of the $303.3 million Medicare paid during that period was improper.

Beneficiaries shared the cost: the inspector general estimated approximately $8.8 million in associated coinsurance.

The audit predates the major billing surge. In a separate look at later claims, the inspector general found 125,426 curved-tip catheter claims for female enrollees in 2023, compared with 2,753 during the audit period. The inspector general shared the supplier patterns with the Centers for Medicare & Medicaid Services.

For an insider, that pattern directs attention to the underlying charts. The medical record has to explain the curved-tip choice. The delivery record has to explain what reached the patient. A large claims file can identify where to look. People inside the operation can explain what happened there.

Operation Gold Rush and the Purchase of Enrolled Suppliers

The health care fraud indictment described in the Justice Department’s June 2025 Operation Gold Rush announcement alleged that an organization bought dozens of durable medical equipment companies that could already bill Medicare and supplemental insurers. It allegedly paid people to serve as owners on paper, created fictitious corporate records and concealed control by leaders overseas.

According to that account of the indictment, the organization used stolen identities to submit claims through the acquired companies. It recruited replacement owners and acquired replacement businesses as authorities shut companies down. The existing enrollment was part of what the organization was buying.

The government’s allegations make the ownership paperwork worth comparing with the operating records: who acquired the company, who controlled its accounts, who submitted the claims and what fulfillment activity accompanied them. A billing business can change hands while retaining the credentials that let its claims enter Medicare.

When a Catheter Claim Says Paid, Did Cash Leave Medicare?

A catheter claim’s paid field can show paid while payment is suspended and cash has not been disbursed. The claims data may also show an amount that was never issued or was offset against a debt. To establish the cash movement, we connect the claim to the payment and suspension records.

In its account of the Gold Rush criminal charges, the Justice Department alleged that the organization submitted over $10.6 billion in false Medicare claims for durable medical equipment. Its national takedown announcement said the companies actually received approximately $41 million from Medicare.

The department separately estimated nearly $900 million in payments from Medicare supplemental insurers. The Medicare controls left another payer exposed.

The Government Accountability Office’s 2026 review adds a related catheter finding. For a group of 15 providers billing in 2023 and 2024, the Centers for Medicare & Medicaid Services said payment suspensions prevented more than 99 percent of payments. The Government Accountability Office also reported that private payers may have paid tens of millions of dollars in beneficiary cost-sharing.

That distinction matters to an accountable care organization analyst reading an expenditure file and to a billing employee reading a remittance. The payment field identifies what the claim system recorded. The disbursement records establish where the money went.

Why ACOs Saw Catheter Claims in Their Own Results

Accountable care organizations compare spending for their assigned beneficiaries with a benchmark. A catheter claim can therefore affect an accountable care organization’s financial results even when its clinicians never ordered the supplies.

In its April 2024 coalition letter, the National Association of ACOs reported an Institute for Accountable Care analysis of paid amounts, a different measure from the allowed charges above, putting spending on two catheter codes at $3.1 billion in 2023. Almost all the increase was attributed to ten suppliers. The Centers for Medicare & Medicaid Services acknowledged that numerous accountable care organizations had raised concerns about the effect of catheter billing on their expenditures.

The agency’s catheter adjustment removed the specified A4352 and A4353 amounts from Shared Savings Program calculations for 2023. The agency declined to add the straight-tip code. The adjustment addressed what spending counted toward shared savings and losses.

An accountable care organization analyst can bring the population view: which suppliers’ claims appeared, which patients were affected and whether the clinical encounters explain the supply claims. A supplier employee can bring the order and shipment history. Those views can answer each other’s questions.

The Payment Incentive and the Controls Around It

Catheter reimbursement left substantial room above the price of the product. In its 2022 payment-rate study, the HHS inspector general found that Medicare and beneficiaries paid $407 million for intermittent catheters in fiscal year 2020, while suppliers spent approximately $121 million acquiring them. The inspector general recommended lower payment rates while preserving access to the catheters patients needed.

As of July 2026, Medicare did not require prior authorization for intermittent catheters.

The Centers for Medicare & Medicaid Services also addressed entry into the business. Its February 2026 enrollment notice described catheter suppliers that had recently changed ownership and billed for supplies physicians had not ordered and beneficiaries had not received or needed. The notice imposed a six-month nationwide moratorium on new enrollment for specified medical-equipment supplier types.

Further changes are scheduled through the next round of competitive bidding, including nationwide delivery categories for urological supplies and hydrophilic urinary catheters.

Can a Doctor’s Office Get a Kickback for Referrals?

Not lawfully, but it happens. A referral kickback can take the form of discounts, free supplies or other benefits. The separate C.R. Bard and Liberator Medical Supply healthcare kickback case shows how a prescription form can become part of that arrangement.

In January 2025, Bard agreed to a $17 million civil settlement over allegations that free samples and discounts encouraged urology practices to use its Link prescription form. The government alleged that the benefits included excessive free samples and savings on in-office supplies.

The form listed Bard catheter products. According to the government, sales representatives encouraged practices to make it their standard prescription form. After Bard acquired Liberator, the alleged strategy also steered prescriptions through its own equipment supplier. The form could influence both the product prescribed and the business filling the order.

A practice employee sees which form becomes standard. A sales employee may know what discounts or samples accompanied that decision. The referral and fulfillment records show where the resulting prescriptions went. The alleged benefits favored Bard products and its supplier over competitors.

A former employee of another medical supply company brought the whistleblower case behind the settlement. The case puts an industry witness at the point where sales practices and catheter referrals meet.

What Evidence Is Needed for Reporting Fraud?

Useful catheter evidence connects the beneficiary, clinical need, order, product, delivery, refill and claim to the people making the decisions. Order versions and transmission records can explain when the paperwork appeared. Contact and shipping histories can explain whether a recurring bill followed an actual request and delivery. Ownership and payment records can identify who controlled the business and received the money.

The most useful account also explains what the employee saw: a claim submitted despite a missing order, a refill contact recorded after shipment, or a benefit offered to obtain prescriptions. We work with you to connect those observations to the business records and assess a False Claims Act case.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Know How the Claims Were Made

If you work with catheter orders, shipments, referrals or accountable care claims and can explain where the patient record and the billing part company, speak with our whistleblower experts about what you see. We build your strongest catheter fraud whistleblower case with you, bring in Medicare fraud whistleblower lawyers who understand supplier billing and referral arrangements, and stay beside you throughout the process.